Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Stock
Equities
688621
CNE100005139
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
49.51 CNY | +0.45% | -2.19% | -29.02% |
Sales 2024 * | 1.26B 174M | Sales 2025 * | 1.65B 228M | Capitalization | 5.55B 766M |
---|---|---|---|---|---|
Net income 2024 * | 277M 38.25M | Net income 2025 * | 388M 53.58M | EV / Sales 2024 * | 4.4 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.35 x |
P/E ratio 2024 * |
20
x | P/E ratio 2025 * |
12.5
x | Employees | 1,370 |
Yield 2024 * |
1.39% | Yield 2025 * |
1.84% | Free-Float | 52.15% |
1 day | +0.45% | ||
1 week | -2.19% | ||
1 month | -12.14% | ||
3 months | -18.38% | ||
6 months | -27.36% | ||
Current year | -29.02% |
Managers | Title | Age | Since |
---|---|---|---|
Yu Jing Liu
CEO | Chief Executive Officer | 42 | 09-02-28 |
Ling Yang Zhao
DFI | Director of Finance/CFO | 36 | 20-03-20 |
Ming Juan Wang
CTO | Chief Tech/Sci/R&D Officer | 48 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Qian Li
CHM | Chairman | 43 | 09-03-08 |
Qiao Chen
BRD | Director/Board Member | 44 | 20-03-20 |
Zhuang Kun He
BRD | Director/Board Member | 52 | 20-03-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 49.51 | +0.45% | 586,820 |
24-05-30 | 49.29 | +0.96% | 779,826 |
24-05-29 | 48.82 | -0.63% | 810,564 |
24-05-28 | 49.13 | +0.45% | 763,223 |
24-05-27 | 48.91 | -3.38% | 2,210,151 |
End-of-day quote Shanghai S.E., May 30, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.02% | 762M | |
+43.36% | 58.06B | |
-5.31% | 40.53B | |
+37.52% | 38.99B | |
+14.75% | 26.7B | |
-12.56% | 26.56B | |
-22.45% | 18.98B | |
+0.04% | 12.17B | |
+25.12% | 12B | |
+26.04% | 11.92B |
- Stock Market
- Equities
- 688621 Stock